VERTEX PHARMACEUTICALS INC / MA Repayments of Advances for Construction
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Repayments of Advances for Construction of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfAdvancesForConstruction · last filed 2016-02-16
- VERTEX PHARMACEUTICALS INC / MA repayments of advances for construction for fiscal 2015 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA repayments of advances for construction for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- VERTEX PHARMACEUTICALS INC / MA repayments of advances for construction for fiscal 2013 was $58.43M.
| Period end | Repayments of Advances for Construction 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-16 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-16 |
| 2013-12-31 | $58.43M 10-K · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |